A20 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The A20 cell line is derived from a reticulum cell sarcoma in a mouse and is widely used in immunology and cancer research. Reticulum cell sarcoma is a type of B-cell lymphoma, and A20 cells provide a valuable model for studying the biology of B-cell lymphomas and the immune response. These cells are particularly useful for investigating the mechanisms of B-cell development, activation, signaling, and the interaction between tumor cells and the immune system. Additionally, A20 cells play a crucial role in research focused on the production and function of cytokines, which are essential for immune regulation. A20 cells display a lymphoblastic morphology and express surface markers typical of B-cells, including surface immunoglobulin and major histocompatibility complex (MHC) molecules. Researchers utilize A20 cells to study antigen presentation, B-cell receptor signaling, and the role of various cytokines in immune responses. These cells are also instrumental in the development and testing of immunotherapies, such as monoclonal antibodies and checkpoint inhibitors, aimed at treating B-cell lymphomas and other hematological malignancies. Additionally, A20 cells serve as a model for evaluating the efficacy and safety of novel therapeutic agents in preclinical studies. The utility of A20 cells in immunological research and the understanding of B-cell pathophysiology highlights their importance in advancing cancer research and developing new treatment strategies. |
|---|---|
| Organism | Mouse |
| Disease | Mouse reticulum cell sarcoma |
| Synonyms | A-20 |
Characteristics
| Breed/Subspecies | BALB/cAnN |
|---|---|
| Age | >15 months |
| Gender | Unspecified |
| Morphology | Lymphoblast |
| Cell type | B lymphocyte |
| Growth properties | Suspension |
Regulatory Data
| Citation | A20 (Cytion catalog number 305263) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_1940 |
Biomolecular Data
| Tumorigenic | Yes |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS, add 2.5 g/L glucose and 10 mM HEPES |
| Subculturing | Suspension cells: Remove cells from substrate by pipetting with fresh medium. To obtain single cells, pass the suspension several times through a 22 gauge needle and dispense into new flasks. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305263-120824 | Certificate of Analysis | 15. Apr. 2025 | 305263 |